Zabofloxacin D-aspartate

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameZabofloxacin D-aspartate
Drug Alias NameDW-224aa
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDong Wha Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A